GARP

GARP (PF3D7_0113000) is an ~80 kDa glutamic acid-rich protein of Plasmodium falciparum that is exported to the exofacial surface of erythrocytes infected by early-to-late trophozoite-stage parasites, where it functions in host-cell remodeling and cytoadherence-related interactions (PMID:32427965). GARP contains lysine-rich tandemly repeated sequences that are themselves sufficient to direct proteins to the erythrocyte periphery, and these repeat-based targeting signals arose through repeat expansion with targeting efficiency scaling with repeat number (PMID:27777305). Functionally distinct repeat domains separate immune epitopes from a core erythrocyte-binding activity: GARP acts as a secreted parasite ligand for the ectodomain of human erythrocyte band 3 (anion exchanger AE1/SLC4A1), and synthetic peptides from its erythrocyte-binding repeats induce erythrocyte aggregation resembling rosetting (PMID:30545833). At the infected-erythrocyte surface, GARP assembles into a knob-associated complex with Parasite-Infected Erythrocyte Specific Protein-2 (PIESP2), the two proteins co-localizing to the surface of knob-like protrusions (PMID:42336280). Engagement of surface GARP by antibodies kills trophozoite-infected erythrocytes by triggering programmed cell death in the intracellular parasite, marked by crisis-form morphology, loss of mitochondrial membrane potential, food vacuole disintegration, caspase-like cysteine protease activation, and chromosomal DNA fragmentation (PMID:32427965, PMID:35881381). Growth inhibition seen with polyclonal anti-GARP serum is not attributable to GARP itself, as a GARP-specific monoclonal antibody does not affect invasion or growth (PMID:38298126).

1. 1988 Low

   Establishing that a discrete glutamic acid-rich gene exists in P. falciparum defined GARP as a distinct molecular entity and provided the sequence framework for all later functional work.

   Evidence Gene cloning and sequencing defining gene structure

   PMID:2903445

   Open questions at the time

   • Single structural/sequencing study with no functional assay
   • No localization, binding partner, or phenotype established
   • Role of glutamic acid-rich content not addressed
2. 2016 Medium

   The question of how GARP reaches the erythrocyte surface was addressed by showing its lysine-rich tandem repeats are autonomous, repeat-number-dependent targeting signals for the erythrocyte periphery.

   Evidence Transfection of repeat-containing reporter fusions with fluorescence localization in P. falciparum and P. knowlesi

   PMID:27777305

   Open questions at the time

   • Molecular machinery recognizing the lysine-rich signal not identified
   • Whether targeting requires other GARP domains not resolved
   • Endogenous trafficking route not directly mapped
3. 2018 Medium

   The host-side function of GARP was defined by identifying erythrocyte band 3 (SLC4A1) as a receptor and separating immune-epitope repeats from erythrocyte-binding repeats, linking GARP to erythrocyte aggregation/rosetting.

   Evidence Phage display cDNA screening, synthetic-peptide domain mapping, and erythrocyte aggregation assays

   PMID:30545833

   Open questions at the time

   • Binding stoichiometry and affinity to band 3 not quantified
   • In vivo contribution to rosetting not tested
   • Structure of the binding interface unknown
4. 2020 High

   Whether surface GARP could be an antibody target was answered by showing it is displayed on trophozoite-infected erythrocytes and that anti-GARP antibodies kill parasites by inducing programmed cell death.

   Evidence Surface flow cytometry, in vitro killing assays, and multiple apoptosis readouts, with an NHP challenge model

   PMID:32427965

   Open questions at the time

   • Signaling pathway linking surface antibody binding to intracellular apoptosis not defined
   • Identity of the caspase-like protease not established
   • Whether GARP itself transduces the death signal unresolved
5. 2022 Medium

   A methodological characterization consolidated the apoptotic phenotype of anti-GARP-treated infected erythrocytes across independent readouts, standardizing the death signature.

   Evidence Mitochondrial membrane potential, food vacuole integrity, caspase-like activity, and DNA fragmentation assays on antibody-treated infected erythrocytes

   PMID:35881381

   Open questions at the time

   • Corroborative/methodological rather than novel mechanism
   • Upstream trigger of the apoptotic cascade still unmapped
   • No genetic dissection of the death pathway
6. 2024 Medium

   The specificity of anti-GARP protective activity was tested, revealing that polyclonal growth inhibition is GARP-independent because a GARP-targeting monoclonal antibody does not affect invasion or growth.

   Evidence In vitro growth inhibition assays comparing polyclonal anti-GARP serum and monoclonal mAb7899

   PMID:38298126

   Open questions at the time

   • Identity of the actual growth-inhibitory target(s) unknown
   • Reconciliation with earlier antibody-mediated killing not fully resolved
   • Whether mAb7899 engages the functionally relevant epitope untested
7. 2026 High

   The surface organization of GARP was clarified by demonstrating it forms a knob-associated complex with PIESP2, placing GARP in a defined molecular assembly at knob protrusions.

   Evidence Phage display, monoclonal antibody epitope mapping, unbiased mass spectrometry, and two independent GARP-null parasite lines with immunofluorescence

   PMID:42336280

   Open questions at the time

   • Direct physical interaction interface between GARP and PIESP2 not resolved structurally
   • Functional consequence of the complex for adhesion or antibody-mediated killing untested
   • Stoichiometry and other complex members not defined

• How antibody engagement of surface GARP is transduced across the erythrocyte membrane into an intracellular apoptotic cascade, and how the band 3-binding and PIESP2-complex functions integrate, remain unresolved.
• No defined signal-transduction pathway from surface GARP to parasite apoptosis
• Structural basis of band 3 binding and PIESP2 complex assembly unknown
• Genetic phenotype of GARP-null parasites on adhesion/rosetting not reported